PMID- 11784721 OWN - NLM STAT- MEDLINE DCOM- 20020429 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 277 IP - 12 DP - 2002 Mar 22 TI - Insulin regulation of insulin-like growth factor-binding protein-1 gene expression is dependent on the mammalian target of rapamycin, but independent of ribosomal S6 kinase activity. PG - 9889-95 AB - Insulin inhibits the expression of the hepatic insulin-like growth factor-binding protein-1 (IGFBP-1) and glucose-6-phosphatase (G6Pase) genes. The signaling pathway that mediates these events requires the activation of phosphatidylinositol 3-kinase, whereas transfection studies have suggested an involvement of Akt (protein kinase B) and FKHR, a transcription factor regulated by Akt. We now demonstrate that insulin repression of endogenous IGFBP-1 gene transcription was blocked by rapamycin or by amino acid starvation. Rapamycin inhibited the mammalian target of rapamycin (mTOR) and the subsequent activation of p70/p85 S6 protein kinase-1 (S6K1) by insulin, whereas amino acid depletion prevented insulin induction of these signaling molecules. Importantly, we demonstrate that insulin regulation of the thymine-rich insulin response element of the IGFBP-1 promoter was also inhibited by rapamycin. However, sustained activation of S6K1 did not repress this promoter. In addition, rapamycin did not affect insulin regulation of G6Pase expression or Akt activation. We propose that these observations indicate that an mTOR-dependent, but S6K-independent mechanism regulates the suppression of IGFBP-1 (but not G6Pase) gene expression by insulin. Therefore, although the insulin-responsive sequence of the G6Pase gene promoter is related to that of the IGFBP-1 promoter, the signaling pathways that mediate suppression of these genes are distinct. FAU - Patel, Satish AU - Patel S AD - Division of Cellular Signalling, School of Life Sciences, Wellcome Trust Biocentre/Medical Sciences Institute Complex, Dow Street, University of Dundee, Dundee DD1 5EH, United Kingdom. FAU - Lochhead, Pamela A AU - Lochhead PA FAU - Rena, Graham AU - Rena G FAU - Fumagalli, Stefano AU - Fumagalli S FAU - Pende, Mario AU - Pende M FAU - Kozma, Sara C AU - Kozma SC FAU - Thomas, George AU - Thomas G FAU - Sutherland, Calum AU - Sutherland C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20020109 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Culture Media, Serum-Free) RN - 0 (DNA, Complementary) RN - 0 (Enzyme Inhibitors) RN - 0 (Insulin) RN - 0 (Insulin-Like Growth Factor Binding Protein 1) RN - 63231-63-0 (RNA) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases) RN - EC 3.1.- (Ribonucleases) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - Adenoviridae/genetics MH - Amino Acid Motifs MH - Animals MH - Blotting, Western MH - Cell Line MH - Culture Media, Serum-Free/pharmacology MH - DNA, Complementary/metabolism MH - Dose-Response Relationship, Drug MH - Enzyme Activation MH - Enzyme Inhibitors/pharmacology MH - *Gene Expression Regulation MH - Humans MH - Insulin/*metabolism MH - Insulin-Like Growth Factor Binding Protein 1/*metabolism MH - Phosphatidylinositol 3-Kinases/metabolism MH - Plasmids/metabolism MH - Precipitin Tests MH - Promoter Regions, Genetic MH - Protein Binding MH - RNA/metabolism MH - Rats MH - Ribonucleases/metabolism MH - Ribosomal Protein S6 Kinases/*metabolism MH - Signal Transduction MH - Sirolimus/*pharmacology MH - Time Factors MH - Transcription, Genetic MH - Transfection MH - Tumor Cells, Cultured EDAT- 2002/01/11 10:00 MHDA- 2002/05/01 10:01 CRDT- 2002/01/11 10:00 PHST- 2002/01/11 10:00 [pubmed] PHST- 2002/05/01 10:01 [medline] PHST- 2002/01/11 10:00 [entrez] AID - S0021-9258(19)36112-5 [pii] AID - 10.1074/jbc.M109870200 [doi] PST - ppublish SO - J Biol Chem. 2002 Mar 22;277(12):9889-95. doi: 10.1074/jbc.M109870200. Epub 2002 Jan 9.